Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations
- PMID: 18458227
- DOI: 10.1212/01.wnl.0000311275.89032.22
Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations
Abstract
Objective: Severe early-onset axonal neuropathy (SEOAN) is a heterogeneous phenotype first delineated by Ouvrier et al., characterized by progressive axonal degeneration with gait problems often progressing to wheelchair requirement and later respiratory involvement. Most cases are sporadic single cases. Some have heterozygous mitofusin 2 (MFN2) mutations, many of which are de novo dominant mutations. The aim of this study was to investigate the mode of inheritance in three individuals with severe early-onset axonal neuropathy and homozygous or compound heterozygous MFN2 mutations.
Methods: The clinical and molecular findings in the parents of three individuals with SEOAN with homozygous or compound heterozygous MFN2 mutations were examined.
Results: All parents were asymptomatic or mildly symptomatic with some signs of peripheral neuropathy indicating a minimal phenotype. Two had hearing problems. All parents carried the relevant single base (heterozygous) MFN2 variations.
Conclusion: Severe early-onset axonal neuropathy due to MFN2 mutations can present as an apparently recessively inherited neuropathy but the minimal phenotype in the parents suggests a semi-dominant mechanism.
Similar articles
-
Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene.Neurology. 2005 Jul 26;65(2):197-204. doi: 10.1212/01.wnl.0000168898.76071.70. Neurology. 2005. PMID: 16043786
-
Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.Brain. 2006 Aug;129(Pt 8):2103-18. doi: 10.1093/brain/awl174. Epub 2006 Jul 10. Brain. 2006. PMID: 16835246
-
Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations.Arch Neurol. 2009 Dec;66(12):1511-6. doi: 10.1001/archneurol.2009.284. Arch Neurol. 2009. PMID: 20008656
-
Mechanisms of disease and clinical features of mutations of the gene for mitofusin 2: an important cause of hereditary peripheral neuropathy with striking clinical variability in children and adults.Dev Med Child Neurol. 2010 Apr;52(4):328-30. doi: 10.1111/j.1469-8749.2010.03613.x. Epub 2010 Feb 12. Dev Med Child Neurol. 2010. PMID: 20163430 Review.
-
[Molecular genetics of inherited neuropathies].Rinsho Shinkeigaku. 2006 Jan;46(1):1-18. Rinsho Shinkeigaku. 2006. PMID: 16541790 Review. Japanese.
Cited by
-
Bi-allelic Pro291Leu variant in KCNQ4 leads to early onset non-syndromic hearing loss.Gene. 2019 Jul 15;705:109-112. doi: 10.1016/j.gene.2019.04.064. Epub 2019 Apr 24. Gene. 2019. PMID: 31028865 Free PMC article.
-
The Peripheral Nervous System in Amyotrophic Lateral Sclerosis: Opportunities for Translational Research.Front Neurosci. 2019 Jun 25;13:601. doi: 10.3389/fnins.2019.00601. eCollection 2019. Front Neurosci. 2019. PMID: 31293369 Free PMC article. Review.
-
Disease Modeling and Therapeutic Strategies in CMT2A: State of the Art.Mol Neurobiol. 2019 Sep;56(9):6460-6471. doi: 10.1007/s12035-019-1533-2. Epub 2019 Mar 4. Mol Neurobiol. 2019. PMID: 30830587 Review.
-
Genetic Survey of Autosomal Recessive Peripheral Neuropathy Cases Unravels High Genetic Heterogeneity in a Turkish Cohort.Neurol Genet. 2021 Aug 31;7(5):e621. doi: 10.1212/NXG.0000000000000621. eCollection 2021 Oct. Neurol Genet. 2021. PMID: 34476298 Free PMC article.
-
Sensory-Motor Neuropathy in Mfn2 T105M Knock-in Mice and Its Reversal by a Novel Piperine-Derived Mitofusin Activator.J Pharmacol Exp Ther. 2024 Oct 18;391(2):361-374. doi: 10.1124/jpet.124.002258. J Pharmacol Exp Ther. 2024. PMID: 39284622 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases